Teachers Advisors LLC trimmed its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.1% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 535,909 shares of the medical research company’s stock after selling 6,041 shares during the period. Teachers Advisors LLC owned 0.13% of Thermo Fisher Scientific worth $101,758,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Longview Partners Guernsey LTD raised its position in Thermo Fisher Scientific by 6.8% during the 4th quarter. Longview Partners Guernsey LTD now owns 4,876,890 shares of the medical research company’s stock worth $926,024,000 after purchasing an additional 311,977 shares during the last quarter. Geode Capital Management LLC raised its position in Thermo Fisher Scientific by 4.2% during the 4th quarter. Geode Capital Management LLC now owns 3,917,221 shares of the medical research company’s stock worth $742,108,000 after purchasing an additional 158,961 shares during the last quarter. Veritas Asset Management LLP raised its position in Thermo Fisher Scientific by 44.1% during the 3rd quarter. Veritas Asset Management LLP now owns 3,503,259 shares of the medical research company’s stock worth $662,817,000 after purchasing an additional 1,072,500 shares during the last quarter. Wells Fargo & Company MN raised its position in Thermo Fisher Scientific by 2.8% during the 4th quarter. Wells Fargo & Company MN now owns 3,189,088 shares of the medical research company’s stock worth $605,543,000 after purchasing an additional 85,751 shares during the last quarter. Finally, Clearbridge Investments LLC raised its position in Thermo Fisher Scientific by 5.3% during the 4th quarter. Clearbridge Investments LLC now owns 2,862,399 shares of the medical research company’s stock worth $543,512,000 after purchasing an additional 143,518 shares during the last quarter. Institutional investors own 87.67% of the company’s stock.

Get Thermo Fisher Scientific alerts:

Shares of Thermo Fisher Scientific Inc. (TMO) opened at $215.12 on Wednesday. The company has a current ratio of 1.34, a quick ratio of 0.92 and a debt-to-equity ratio of 0.74. Thermo Fisher Scientific Inc. has a 1-year low of $151.74 and a 1-year high of $226.44. The firm has a market capitalization of $87,384.02, a PE ratio of 38.41, a price-to-earnings-growth ratio of 1.59 and a beta of 1.15.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, January 31st. The medical research company reported $2.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.66 by $0.13. Thermo Fisher Scientific had a return on equity of 16.01% and a net margin of 10.64%. The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.72 billion. During the same period last year, the business posted $2.41 EPS. The business’s revenue was up 22.1% compared to the same quarter last year. sell-side analysts predict that Thermo Fisher Scientific Inc. will post 10.81 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Thursday, March 15th will be issued a dividend of $0.17 per share. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date is Wednesday, March 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.71%.

Several research analysts recently issued reports on TMO shares. Leerink Swann reaffirmed an “outperform” rating and set a $239.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Thursday, February 1st. They noted that the move was a valuation call. Evercore ISI started coverage on Thermo Fisher Scientific in a research report on Wednesday, January 3rd. They set an “outperform” rating and a $220.00 target price for the company. Bank of America raised their target price on Thermo Fisher Scientific from $235.00 to $250.00 and gave the stock a “buy” rating in a research report on Thursday, February 1st. ValuEngine raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Finally, Barclays raised their target price on Thermo Fisher Scientific from $225.00 to $245.00 and gave the stock an “overweight” rating in a research report on Thursday, February 1st. Two investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $220.50.

In other news, insider Patrick M. Durbin sold 6,000 shares of the firm’s stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $217.55, for a total value of $1,305,300.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Gregory J. Herrema sold 33,327 shares of the firm’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $219.70, for a total value of $7,321,941.90. Following the completion of the sale, the senior vice president now owns 60,471 shares of the company’s stock, valued at $13,285,478.70. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 98,827 shares of company stock valued at $20,193,272. Company insiders own 0.49% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Teachers Advisors LLC Reduces Stake in Thermo Fisher Scientific Inc. (TMO)” was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this report can be accessed at https://www.americanbankingnews.com/2018/03/14/teachers-advisors-llc-reduces-stake-in-thermo-fisher-scientific-inc-tmo.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.